Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...

A doctor's video reveals how liver disease impacts brain health. When the liver fails to filter toxins, they accumulate and ...

Fingernails reflect internal health. Changes in nail color or texture may signal health problems. Pale nails may indicate ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Novo Nordisk A/S’s weight-loss drug Wegovy has received FDA approval to treat a serious form of liver disease, giving the ...

China: A large-scale U.S. analysis has revealed that people living with both type 2 diabetes (T2DM) and chronic kidney ...

Ian "Big E" Berger has been a Miami Dolphins fans for 40 years, but he is fighting a life-threatening liver condition.

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

In this article, we will share our expert’s insights on whether intermittent fasting is a wise choice for those living with ...

Fatty liver disease, a growing concern, affects one in three adults globally. Simple dietary errors like consuming excess ...

Chronic venous insufficiency is often mistaken for normal ageing in seniors, delaying treatment and leading to ulcers, skin damage and mobility loss. Firstpost brings out expert’s views on how CVI ...

The new approval allows the GLP-1 to be used to treat adults with the liver disease metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring. Wegovy is the first GLP-1 to receive ...